In a resounding victory for medical and public health research, the United States Court of Appeals for the First Circuit has upheld a permanent injunction against a Trump administration policy that looked to slash billions in critical funding. Michigan Attorney General Dana Nessel, along with a coalition of 21 other attorneys general, led the charge in preserving the much-needed financial support that fuels innovation and discovery in institutions nationwide.
Reacting to the appellate decision, AG Nessel said, "The Trump administration repeatedly has shown that they will illegally slash funding at the expense of Michiganders, even when that funding supports lifesaving research." She continued with a commitment to Michigan families and their universities, asserting that she would "I am relieved that courts have time and again stepped in to restore these funds and uphold the rule of law. I will continue to protect Michigan families, universities, and research institutions from these unlawful and harmful federal actions," as reported in a press release. It's a sentiment echoed across states as their leadership stood against the federal cuts.
It was February 10, 2025, when AG Nessel and her fellow attorneys general took action against the administration, resulting in a Massachusetts district court judge blocking the NIH funding reductions less than a day later. The recent ruling by the First Circuit solidifies the protection over these crucial funds, ensuring that research—spanning genetic breakthroughs to cancer treatments—remains well-supported, as mentioned on the Department of the Attorney General's official website.
The importance of NIH funding can hardly be overstated; it is the foundation upon which medical breakthroughs are often built, and it has historically led to advancements such as the sequencing of DNA and treatment modalities for various cancers. Recognizing this, the coalition of attorneys general banded together in defense of science and innovation—demonstrating the collective power of states that lean on such federal support for advancements in health and science.
This ruling not only signifies a check against administrative overreach but also actively safeguards the landscape of American scientific research. With dozens of NIH-supported scientists earning Nobel Prizes for their work, the court's affirmation ensures that the United States continues its proud tradition of leading the charge in cutting-edge, life-altering medical discoveries. As AG Nessel and her colleagues have shown, the legal system can indeed serve as a bulwark, preserving the integral seams of public health and innovation against fraying policy decisions.
